Endogenous cellular prion protein regulates contractility of the mouse ileum

Neurogastroenterology and Motility

Volumn 24, Issue 9, 2012, Pages

  Martin, G R ^a,b   Alvarez, A L ^a,b   Bashashati, M ^a   Keenan, C M ^a   Jirik, F R ^b   Sharkey, K A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Copper; Enteric glia; Enteric nervous system; Myenteric plexus; Nitric oxide

Indexed keywords

CHELATING AGENT; COPPER; NITRIC OXIDE DONOR; NUCLEOSIDE TRIPHOSPHATE; NUCLEOTIDASE; PRION PROTEIN; REGULATOR PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; GLIA; GUINEA PIG; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE CONTRACTION; MOUSE; MUSCLE RELAXATION; MYENTERIC PLEXUS; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WILD TYPE;

ANIMALS; CHELATING AGENTS; COPPER; ENTERIC NERVOUS SYSTEM; GUINEA PIGS; ILEUM; MALE; MICE; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NEUROGLIA; NEURONS; PRPC PROTEINS;

EID: 84865444534     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01970.x     Document Type: Article

References (61)

1. Aguzzi A, Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 2004; 116: 313-27.
2. Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987; 51: 229-40.
3. Schatzl HM, Da Costa M, Taylor L, Cohen FE, Prusiner SB. Prion protein gene variation among primates. J Mol Biol 1995; 245: 362-74.
4. Kurschner C, Morgan JI. Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res Mol Brain Res 1996; 37: 249-58.
5. Vassallo N, Herms J, Behrens C et al. Activation of phosphatidylinositol in 3-kinase by cellular prion protein and its role cell survival. Biochem Biophysical Res Comm 2005; 332: 75-82.
6. Mouillet-Richard S, Ermonval M, Chebassier C et al. Signal transduction through prion protein. Science 2000; 289: 1925-8.
7. Schneider B, Mutel V, Pietri M, Ermonval M, Mouillet-Richard S, Kellermann O. NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci U S A 2003; 100: 13326-31.
8. Biasini E, Turnbaugh JA, Unterberger U, Harris DA. Prion protein at the crossroads of physiology and disease. Trends Neurosci 2012; 35: 92-103.
9. Khosravani H, Zhang Y, Tsutsui S et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008; 181: 551-65.
10. Brown DR, Nicholas RS, Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 2002; 67: 211-24.
11. Moya KL, Sales N, Hassig R, Creminon C, Grassi J, Di Giamberardino L. Immunolocalization of the cellular prion protein in normal brain. Microsc Res Tech 2000; 50: 58-65.
12. Kanaani J, Prusiner SB, Diacovo J, Baekkeskov S, Legname G. Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J Neurochem 2005; 95: 1373-86.
13. Smith JD, Moylan JS, Hardin BJ et al. Prion protein expression and functional importance in skeletal muscle. Antioxid Redox Signal 2011; 15: 2465-75.
14. Ford MJ, Burton LJ, Morris RJ, Hall SM. Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 2002; 113: 177-92.
15. Shmakov AN, McLennan NF, McBride P et al. Cellular prion protein is expressed in the human enteric nervous system. Nat Med 2000; 6: 840-1.
16. Lemaire-Vieille C, Schulze T, Podevin-Dimster V et al. Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice. Proc Natl Acad Sci U S A 2000; 97: 5422-7.
17. Heggebo R, Press CM, Gunnes G et al. Distribution of prion protein in the ileal Peyer's patch of scrapie-free lambs and lambs naturally and experimentally exposed to the scrapie agent. J Gen Virol 2000; 81: 2327-37.
18. Morel E, Fouquet S, Chateau D et al. The cellular prion protein PrPc is expressed in human enterocytes in cell-cell junctional domains. J Biol Chem 2004; 279: 1499-505.
19. Albanese V, Lawson VA, Hill AF et al. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine. Auton Neurosci 2008; 140: 17-23.
20. Ford MJ, Burton LJ, Li H et al. A marked disparity between the expression of prion protein and its message by neurones of the CNS. Neuroscience 2002; 111: 533-51.
21. Brown DR, Qin K, Herms JW et al. The cellular prion protein binds copper in vivo. Nature 1997; 390: 684-7.
22. Burns CS, Aronoff-Spencer E, Dunham CM et al. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry 2002; 41: 3991-4001.
23. Shyng SL, Moulder KL, Lesko A, Harris DA. The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J Biol Chem 1995; 270: 14793-800.
24. Vey M, Pilkuhn S, Wille H et al. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A 1996; 93: 14945-9.
25. Pushie MJ, Pickering IJ, Martin GR, Tsutsui S, Jirik FR, George GN. Prion protein expression level alters regional copper, iron and zinc content in the mouse brain. Metallomics 2011; 3: 206-14.
26. Vassallo N, Herms J. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 2003; 86: 538-44.
27. You H, Tsutsui S, Hameed S et al. Abeta neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 2012; 109: 1737-42.
28. Madsen E, Gitlin JD. Copper and iron disorders of the brain. Annu Rev Neurosci 2007; 30: 317-37.
29. Lorca RA, Varela-Nallar L, Inestrosa NC, Huidobro-Toro JP. The cellular prion protein prevents copper-induced inhibition of P2X(4) receptors. Int J Alzheimers Dis 2011; 2011: 706576.
30. Plane F, Wigmore S, Angelini GD, Jeremy JY. Effect of copper on nitric oxide synthase and guanylyl cyclase activity in the rat isolated aorta. Br J Pharmacol 1997; 121: 345-50.
31. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88: 673-728.
32. Bueler H, Fischer M, Lang Y et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356: 577-82.
33. Borchelt DR, Davis J, Fischer M et al. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 1996; 13: 159-63.
34. Storr MA, Bashashati M, Hirota C et al. Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice. Neurogastroenterol Motil 2010; 22: 787-96.
35. Adle-Biassette H, Verney C, Peoc'h K et al. Immunohistochemical expression of prion protein (PrPC) in the human forebrain during development. J Neuropathol Exp Neurol 2006; 65: 698-706.
36. MacEachern SJ, Patel BA, McKay DM, Sharkey KA. Nitric oxide regulation of colonic epithelial ion transport: a novel role for enteric glia in the myenteric plexus. J Physiol 2011; 589: 3333-48.
37. Lavoie EG, Gulbransen BD, Martin-Satue M, Aliagas E, Sharkey KA, Sevigny J. Ectonucleotidases in the digestive system: focus on NTPDase3 localization. Am J Physiol Gastrointest Liver Physiol 2011; 300: G608-20.
38. McMahon HT, Bolshakov VY, Janz R, Hammer RE, Siegelbaum SA, Sudhof TC. Synaptophysin, a major synaptic vesicle protein, is not essential for neurotransmitter release. Proc Natl Acad Sci U S A 1996; 93: 4760-4.
39. Gordge MP, Meyer DJ, Hothersall J, Neild GH, Payne NN, Noronha-Dutra A. Copper chelation-induced reduction of the biological activity of s-nitrosothiols. Br J Pharmacol 1995; 114: 1083-9.
40. Martin GR, Keenan CM, Sharkey KA, Jirik FR. Endogenous prion protein attenuates experimentally induced colitis. Am J Pathol 2011; 179: 2290-301.
41. Stubauer G, Giuffre A, Sarti P. Mechanism of s-nitrosothiol formation and degradation mediated by copper ions. J Biol Chem 1999; 274: 28128-33.
42. Brown DR, Schmidt B, Kretzschmar HA. Effects of copper on survival of prion protein knockout neurons and glia. J Neurochem 1998; 70: 1686-93.
43. Brown DR. Prion and prejudice: normal protein and the synapse. Trends Neurosci 2001; 24: 85-90.
44. Calhoun ME, Jucker M, Martin LJ, Thinakaran G, Price DL, Mouton PR. Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol 1996; 25: 821-8.
45. Collinge J, Whittington MA, Sidle KC et al. Prion protein is necessary for normal synaptic function. Nature 1994; 370: 295-7.
46. Colling SB, Collinge J, Jefferys JG. Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 1996; 209: 49-52.
47. Herms JW, Korte S, Gall S, Schneider I, Dunker S, Kretzschmar HA. Altered intracellular calcium homeostasis in cerebellar granule cells of prion protein-deficient mice. J Neurochem 2000; 75: 1487-92.
48. Urso E, Rizzello A, Acierno R et al. Fluorimetric analysis of copper transport mechanisms in the b104 neuroblastoma cell model: a contribution from cellular prion protein to copper supplying. J Membr Biol 2010; 233: 13-21.
49. Watt NT, Taylor DR, Gillott A, Thomas DA, Perera WS, Hooper NM. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J Biol Chem 2005; 280: 35914-21.
50. Aronoff-Spencer E, Burns CS, Avdievich NI et al. Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry 2000; 39: 13760-71.
51. Cuzzocrea S, Persichini T, Dugo L, Colasanti M, Musci G. Copper induces type II nitric oxide synthase in vivo. Free Radic Biol Med 2003; 34: 1253-62.
52. Armendariz AD, Gonzalez M, Loguinov AV, Vulpe CD. Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. Physiol Genomics 2004; 20: 45-54.
53. Varela-Nallar L, Toledo EM, Larrondo LF, Cabral AL, Martins VR, Inestrosa NC. Induction of cellular prion protein gene expression by copper in neurons. Am J Physiol Cell Physiol 2006; 290: C271-81.
54. Schuschke DA, Saari JT, Miller FN. Arteriolar dilation to endotoxin is increased in copper-deficient rats. Inflammation 1997; 21: 45-53.
55. Greenwood-Van Meerveld B, Prodan CI. Abnormal intestinal function related to hypocupremia in a rodent model. Neurogastroenterol Motil 2012; 24: 283-7.
56. Feraudet C, Morel N, Simon S et al. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem 2005; 280: 11247-58.
57. Phillips RJ, Hargrave SL, Rhodes BS, Zopf DA, Powley TL. Quantification of neurons in the myenteric plexus: an evaluation of putative pan-neuronal markers. J Neurosci Methods 2004; 133: 99-107.
58. Miranda A, Pericuesta E, Ramirez MA, Gutierrez-Adan A. Prion protein expression regulates embryonic stem cell pluripotency and differentiation. PLoS One 2011; 6: e18422.
59. Zhang CC, Steele AD, Lindquist S, Lodish HF. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc Natl Acad Sci U S A 2006; 103: 2184-9.
60. Mohanty ST, Cairney CJ, Chantry AD et al. A small molecule modulator of prion protein increases human mesenchymal stem cell lifespan, ex vivo expansion and engraftment to bone marrow in NOD/SCID mice. Stem Cells 2012; 30: 1134-43.
61. Lawson VA, Furness JB, Klemm HM et al. The brain to gut pathway: a possible route of prion transmission. Gut 2010; 59: 1643-51.